Skip to main content

Advertisement

Log in

The ABCD Study of Neurodevelopment: Identifying Neurocircuit Targets for Prevention and Treatment of Adolescent Substance Abuse

  • Substance Use Disorders (FG Moeller, Section Editor)
  • Published:
Current Treatment Options in Psychiatry Aims and scope Submit manuscript

Opinion statement

Substance use disorders (SUD) can be considered developmental disorders in light of their frequent origins in substance initiation during adolescence. Cross-sectional functional magnetic resonance imaging (fMRI) studies of adolescent substance users or adolescents with SUD have indicated aberrations in brain structures or circuits implicated in motivation, self-control, and mood-regulation. However, attributing these differences to the neurotoxicological effects of chronic substance use has been problematic in that these circuits are also aberrant in at-risk children, such as those with prenatal substance exposure, externalizing disorders (such as conduct disorder), or prodromal internalizing disorders such as depression. To better isolate the effects of substance exposure on the adolescent brain, the newly launched Adolescent Brain Cognitive Development (ABCD) study, funded by the National Institutes of Health, will follow the neurodevelopmental trajectories of over 11,000 American 9- to 10-year-olds for 10 years, into emerging adulthood. This study will provide a rich open-access dataset on longitudinal interactions of neurodevelopment, environmental exposures, and childhood psychopathology that confer addiction risk. The ABCD twin study will further clarify genetic versus experiential influences (e.g., substance use) on neurodevelopmental and psychosocial outcomes. Neurocircuitry thought to regulate mood and behavior has been directly normalized by administration of psychoactive medications and by cognitive therapies in adults. Because of this, we contend that ABCD project data will be a crucial resource for prevention and treatment of SUD in adolescence because its cutting-edge neuroimaging and childhood assessments hold potential for discovery of additional targetable brain differences earlier in development that are prognostic of (or aberrant in) SUD. The ABCD sample size will also have the power to illuminate how sex differences, environmental interactions, and other individual differences interact with neurodevelopment to inform treatment in different groups of adolescents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Hingson RW, Heeren T, Winter MR. Age at drinking onset and alcohol dependence: age at onset, duration, and severity. Arch Pediatr Adolesc Med. 2006;160:739–46.

    Article  PubMed  Google Scholar 

  2. Newton-Howes G, Boden JM. Relation between age of first drinking and mental health and alcohol and drug disorders in adulthood: evidence from a 35-year cohort study. Addict Abingdon Engl. 2016;111:637–44.

    Article  CAS  Google Scholar 

  3. Rose JS, Lee C-T, Dierker LC, Selya AS, Mermelstein RJ. Adolescent nicotine dependence symptom profiles and risk for future daily smoking. Addict Behav. 2012;37:1093–100.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Epstein M, Hill KG, Nevell AM, Guttmannova K, Bailey JA, Abbott RD, et al. Trajectories of marijuana use from adolescence into adulthood: environmental and individual correlates. Dev Psychol. 2015;51:1650–63.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Karbach J, Unger K. Executive control training from middle childhood to adolescence. Front Psychol. 2014;5:390.

    PubMed  PubMed Central  Google Scholar 

  6. • van Amelsvoort T, Hernaus D. Effect of pharmacological interventions on the fronto-cingulo-parietal cognitive control network in psychiatric disorders: a transdiagnostic systematic review of fMRI studies. Front Psychiatry. 2016;7:82. This review of non-stimulant medication effects on fMRI signals demonstrates how even across drug mechanisms, effective medications tend to increase activity of general “task-on” networks and mute default-mode networks, which sheds light both on drug action as well as network abnormalities in psychiatric disorders.

    PubMed  PubMed Central  Google Scholar 

  7. Nathan PJ, Phan KL, Harmer CJ, Mehta MA, Bullmore ET. Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery. Curr Opin Pharmacol. 2014;14:54–61.

    Article  CAS  PubMed  Google Scholar 

  8. Litten RZ, Egli M, Heilig M, Cui C, Fertig JB, Ryan ML, et al. Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol. 2012;17:513–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kuntsche E, Knibbe R, Gmel G, Engels R. Who drinks and why? A review of socio-demographic, personality, and contextual issues behind the drinking motives in young people. Addict Behav. 2006;31:1844–57.

    Article  PubMed  Google Scholar 

  10. Bolton JM, Robinson J, Sareen J. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. J Affect Disord. 2009;115:367–75.

    Article  PubMed  Google Scholar 

  11. Babor TF, Hofmann M, DelBoca FK, Hesselbrock V, Meyer RE, Dolinsky ZS, et al. Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry. 1992;49:599–608.

    Article  CAS  PubMed  Google Scholar 

  12. Gilligan SB, Reich T, Cloninger CR. Etiologic heterogeneity in alcoholism. Genet Epidemiol. 1987;4:395–414.

    Article  CAS  PubMed  Google Scholar 

  13. Heilig M, Goldman D, Berrettini W, O’Brien CP. Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci. 2011;12:670–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Blevins CE, Banes KE, Stephens RS, Walker DD, Roffman RA. Motives for marijuana use among heavy-using high school students: an analysis of structure and utility of the comprehensive marijuana motives questionnaire. Addict Behav. 2016;57:42–7.

    Article  PubMed  Google Scholar 

  15. Pang RD, Farrahi L, Glazier S, Sussman S, Leventhal AM. Depressive symptoms, negative urgency and substance use initiation in adolescents. Drug Alcohol Depend. 2014;144:225–30.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wu P, Bird HR, Liu X, Fan B, Fuller C, Shen S, et al. Childhood depressive symptoms and early onset of alcohol use. Pediatrics. 2006;118:1907–15.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kaplow JB, Curran PJ, Angold A, Costello EJ. The prospective relation between dimensions of anxiety and the initiation of adolescent alcohol use. J Clin Child Psychol. 2001;30:316–26.

    Article  CAS  PubMed  Google Scholar 

  18. Lindquist KA, Satpute AB, Wager TD, Weber J, Barrett LF. The brain basis of positive and negative affect: evidence from a meta-analysis of the human neuroimaging literature. Cereb Cortex N Y N 1991. 2016;26:1910–22.

    Google Scholar 

  19. Cole DM, Smith SM, Beckmann CF. Advances and pitfalls in the analysis and interpretation of resting-state FMRI data. Front Syst Neurosci. 2010;4:8.

    PubMed  PubMed Central  Google Scholar 

  20. Peters SK, Dunlop K, Downar J. Cortico-striatal-thalamic loop circuits of the salience network: a central pathway in psychiatric disease and treatment. Front Syst Neurosci. 2016;10:104.

    Article  PubMed  PubMed Central  Google Scholar 

  21. • Mulders PC, van Eijndhoven PF, Schene AH, Beckmann CF, Tendolkar I. Resting-state functional connectivity in major depressive disorder: a review. Neurosci Biobehav Rev. 2015;56:330–44. This is a useful review of converging evidence that a disorder prone to rumination is characterized by robust communication between nodes of a network that is activated by self-referential thinking.

    Article  PubMed  Google Scholar 

  22. Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci. 2007;8:700–11.

    Article  CAS  PubMed  Google Scholar 

  23. Andrews-Hanna JR, Reidler JS, Sepulcre J, Poulin R, Buckner RL. Functional-anatomic fractionation of the brain’s default network. Neuron. 2010;65:550–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Hamilton JP, Farmer M, Fogelman P, Gotlib IH. Depressive rumination, the default-mode network, and the dark matter of clinical neuroscience. Biol Psychiatry. 2015;78:224–30.

    Article  PubMed  PubMed Central  Google Scholar 

  25. • Goodkind M, Eickhoff SB, Oathes DJ, Jiang Y, Chang A, Jones-Hagata LB, et al. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry. 2015;72:305–15. This seminal review of fMRI gray matter volume studies identified structural correlates of what might be a common neurodevelopmental aberration/pathway that underscores a dysregulated brain.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Benegal V, Antony G, Venkatasubramanian G, Jayakumar PN. Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence. Addict Biol. 2007;12:122–32.

    Article  PubMed  Google Scholar 

  27. • Yang X, Tian F, Zhang H, Zeng J, Chen T, Wang S, et al. Cortical and subcortical gray matter shrinkage in alcohol-use disorders: a voxel-based meta-analysis. Neurosci Biobehav Rev. 2016;66:92–103. This review dutifully summarizes findings of gray matter reductions that correlate with diagnoses of AUD, which should be interpreted with the caveat that many reductions have also been found in frequently comorbid mood disorders.

    Article  CAS  PubMed  Google Scholar 

  28. Lippard ETC, Mazure CM, Johnston JAY, Spencer L, Weathers J, Pittman B, et al. Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents. J Neurosci Res. 2017;95:777–91.

    Article  PubMed  Google Scholar 

  29. Goodman M, Carpenter D, Tang CY, Goldstein KE, Avedon J, Fernandez N, et al. Dialectical behavior therapy alters emotion regulation and amygdala activity in patients with borderline personality disorder. J Psychiatr Res. 2014;57:108–16.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Yang TT, Simmons AN, Matthews SC, Tapert SF, Frank GK, Max JE, et al. Adolescents with major depression demonstrate increased amygdala activation. J Am Acad Child Adolesc Psychiatry. 2010;49:42–51.

    PubMed  PubMed Central  Google Scholar 

  31. Schuckit MA, Smith TL, Paulus MP, Tapert SF, Simmons AN, Tolentino NJ, et al. The ability of functional magnetic resonance imaging to predict heavy drinking and alcohol problems 5 years later. Alcohol Clin Exp Res. 2016;40:206–13.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Squeglia LM, Cservenka A. Adolescence and drug use vulnerability: findings from neuroimaging. Curr Opin Behav Sci. 2017;13:164–70.

    Article  PubMed  Google Scholar 

  33. Morgenstern M, Isensee B, Sargent JD, Hanewinkel R. Attitudes as mediators of the longitudinal association between alcohol advertising and youth drinking. Arch Pediatr Adolesc Med. 2011;165:610–6.

    Article  PubMed  Google Scholar 

  34. Harnett PH, Lynch SJ, Gullo MJ, Dawe S, Loxton N. Personality, cognition and hazardous drinking: support for the 2-component approach to reinforcing substances model. Addict Behav. 2013;38:2945–8.

    Article  PubMed  Google Scholar 

  35. Kazemi DM, Flowers C, Shou Q, Levine MJ, Van Horn KR. Personality risk for alcohol consequences among college freshmen. J Psychosoc Nurs Ment Health Serv. 2014;52:38–45.

    Article  PubMed  Google Scholar 

  36. Anderson KG, Schweinsburg A, Paulus MP, Brown SA, Tapert S. Examining personality and alcohol expectancies using functional magnetic resonance imaging (fMRI) with adolescents. J Stud Alcohol. 2005;66:323–31.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Evenden JL. Varieties of impulsivity. Psychopharmacol Berl. 1999;146:348–61.

    Article  CAS  Google Scholar 

  38. Swann AC, Bjork JM, Moeller FG, Dougherty DM. Two models of impulsivity: relationship to personality traits and psychopathology. Biol Psychiatry. 2002;51:988–94.

    Article  PubMed  Google Scholar 

  39. Bickel WK, Miller ML, Yi R, Kowal BP, Lindquist DM, Pitcock JA. Behavioral and neuroeconomics of drug addiction: competing neural systems and temporal discounting processes. Drug Alcohol Depend. 2007;90(Suppl 1):S85–91.

    Article  PubMed  Google Scholar 

  40. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci. 2005;8:1458–63.

    Article  CAS  PubMed  Google Scholar 

  41. Bartra O, McGuire JT, Kable JW. The valuation system: a coordinate-based meta-analysis of BOLD fMRI experiments examining neural correlates of subjective value. NeuroImage. 2013;76:412–27.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hare TA, Camerer CF, Rangel A. Self-control in decision-making involves modulation of the vmPFC valuation system. Science. 2009;324:646–8.

    Article  CAS  PubMed  Google Scholar 

  43. Kable JW, Glimcher PW. The neural correlates of subjective value during intertemporal choice. Nat Neurosci. 2007;10:1625–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Schacter DL, Addis DR, Hassabis D, Martin VC, Spreng RN, Szpunar KK. The future of memory: remembering, imagining, and the brain. Neuron. 2012;76:677–94.

    Article  CAS  PubMed  Google Scholar 

  45. Crews FT, Boettiger CA. Impulsivity, frontal lobes and risk for addiction. Pharmacol Biochem Behav. 2009;93:237–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Nigg JT, Wong MM, Martel MM, Jester JM, Puttler LI, Glass JM, et al. Poor response inhibition as a predictor of problem drinking and illicit drug use in adolescents at risk for alcoholism and other substance use disorders. J Am Acad Child Adolesc Psychiatry. 2006;45:468–75.

    Article  PubMed  Google Scholar 

  47. Pardini D, White HR, Stouthamer-Loeber M. Early adolescent psychopathology as a predictor of alcohol use disorders by young adulthood. Drug Alcohol Depend. 2007;88(Suppl 1):S38–49.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Byrd AL, Loeber R, Pardini DA. Antisocial behavior, psychopathic features and abnormalities in reward and punishment processing in youth. Clin Child Fam Psychol Rev [Internet]. 2013; Available from: http://www.ncbi.nlm.nih.gov/pubmed/24357109

  49. Bjork JM, Pardini DA. Who are those “risk-taking adolescents”? Individual differences in developmental neuroimaging research. Dev Cogn Neurosci. 2015;11:56–64.

    Article  PubMed  Google Scholar 

  50. Castellanos-Ryan N, Rubia K, Conrod PJ. Response inhibition and reward response bias mediate the predictive relationships between impulsivity and sensation seeking and common and unique variance in conduct disorder and substance misuse. Alcohol Clin Exp Res. 2011;35:140–55.

    Article  PubMed  Google Scholar 

  51. Fernie G, Peeters M, Gullo MJ, Christiansen P, Cole JC, Sumnall H, et al. Multiple behavioural impulsivity tasks predict prospective alcohol involvement in adolescents. Addict Abingdon Engl. 2013;108:1916–23.

    Article  Google Scholar 

  52. Heitzeg MM, Cope LM, Martz ME, Hardee JE. Neuroimaging risk markers for substance abuse: recent findings on inhibitory control and reward system functioning. Curr Addict Rep. 2015;2:91–103.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Heatherton TF, Wagner DD. Cognitive neuroscience of self-regulation failure. Trends Cogn Sci. 2011;15:132–9.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Bjork JM, Knutson B, Hommer DW. Incentive-elicited striatal activation in adolescent children of alcoholics. Addiction. 2008;103:1308–19.

    Article  PubMed  Google Scholar 

  55. Cservenka A, Herting MM, Seghete KLM, Hudson KA, Nagel BJ. High and low sensation seeking adolescents show distinct patterns of brain activity during reward processing. NeuroImage. 2013;66:184–93.

    Article  PubMed  Google Scholar 

  56. Bjork JM, Chen G, Smith AR, Hommer DW. Incentive-elicited mesolimbic activation and externalizing symptomatology in adolescents. J Child Psychol Psychiatry. 2010;51:827–37.

    Article  PubMed  Google Scholar 

  57. • Luijten M, Schellekens AF, Kühn S, Machielse MWJ, Sescousse G. Disruption of reward processing in addiction: an image-based meta-analysis of functional magnetic resonance imaging studies. JAMA Psychiatry. 2017; doi:10.1001/jamapsychiatry.2016.3084. This rigorous analysis relied on actual statistical brain map datasets donated from authors of source papers, not just peak activation coordinates reported in published tables. They show that subjects with addictions tend to show reduced effort-mobilization anticipatory activation to rewards, but more hedonic reactions to rewards once delivered.

    PubMed  Google Scholar 

  58. Luijten M, Machielsen MWJ, Veltman DJ, Hester R, de Haan L, Franken IHA. Systematic review of ERP and fMRI studies investigating inhibitory control and error processing in people with substance dependence and behavioural addictions. J Psychiatry Neurosci JPN. 2014;39:149–69.

    Article  PubMed  Google Scholar 

  59. Weafer J, Dzemidzic M, Eiler W, Oberlin BG, Wang Y, Kareken DA. Associations between regional brain physiology and trait impulsivity, motor inhibition, and impaired control over drinking. Psychiatry Res. 2015;233:81–7.

    Article  PubMed  PubMed Central  Google Scholar 

  60. • Rogers JC, De Brito SA. Cortical and subcortical gray matter volume in youths with conduct problems: a meta-analysis. JAMA Psychiatry. 2016;73:64–72. This review illustrated that many gray matter reductions found in general psychiatric disorders are also found in severe childhood externalizing disorder, as another piece of evidence for common brain mechanisms (or correlates) of psychiatric disturbance.

    Article  PubMed  Google Scholar 

  61. • McTeague LM, Goodkind MS, Etkin A. Transdiagnostic impairment of cognitive control in mental illness. J Psychiatr Res. 2016;83:37–46. An important commentary with supportive evidence that both internalizing and externalizing psychiatric disorders share fundamental cognitive performance decrements, which themselves have been linked to specific neurocircuit functional and structural abnormalities.

    Article  PubMed  Google Scholar 

  62. Friedman NP, Miyake A. Unity and diversity of executive functions: individual differences as a window on cognitive structure. Cortex J Devoted Study Nerv Syst Behav. 2017;86:186–204.

    Article  Google Scholar 

  63. Hugdahl K, Raichle ME, Mitra A, Specht K. On the existence of a generalized non-specific task-dependent network. Front Hum Neurosci. 2015;9:430.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Niendam TA, Laird AR, Ray KL, Dean YM, Glahn DC, Carter CS. Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions. Cogn Affect Behav Neurosci. 2012;12:241–68.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Rubia K, Alegria AA, Cubillo AI, Smith AB, Brammer MJ, Radua J. Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Biol Psychiatry. 2014;76:616–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Anticevic A, Cole MW, Murray JD, Corlett PR, Wang X-J, Krystal JH. The role of default network deactivation in cognition and disease. Trends Cogn Sci. 2012;16:584–92.

    Article  PubMed  PubMed Central  Google Scholar 

  67. • Verdejo-Garcia A. Cognitive training for substance use disorders: neuroscientific mechanisms. Neurosci Biobehav Rev. 2016;68:270–81. Helpful review of non-pharmacological interventions and how they can strengthen top-down control of motivation for substance use, as evidenced by both behavioral outcomes and fMRI signatures.

    Article  PubMed  Google Scholar 

  68. Bickel WK, Yi R, Landes RD, Hill PF, Baxter C. Remember the future: working memory training decreases delay discounting among stimulant addicts. Biol Psychiatry. 2011;69:260–5.

    Article  PubMed  Google Scholar 

  69. Crowther A, Smoski MJ, Minkel J, Moore T, Gibbs D, Petty C, et al. Resting-state connectivity predictors of response to psychotherapy in major depressive disorder. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2015;40:1659–73.

    Article  Google Scholar 

  70. Knutson B, Adams CM, Fong GW, Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci. 2001;21:RC159.

    CAS  PubMed  Google Scholar 

  71. Verbruggen F, Logan GD. Models of response inhibition in the stop-signal and stop-change paradigms. Neurosci Biobehav Rev. 2009;33:647–61.

    Article  PubMed  Google Scholar 

  72. Medina KL, Hanson KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence. J Int Neuropsychol Soc JINS. 2007;13:807–20.

    Article  PubMed  Google Scholar 

  73. Weintraub S, Bauer PJ, Zelazo PD, Wallner-Allen K, Dikmen SS, Heaton RK, et al. I. NIH toolbox cognition battery (CB): introduction and pediatric data. Monogr. Soc. res Child Dev. 2013;78:1–15.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Schmitt JE, Eyler LT, Giedd JN, Kremen WS, Kendler KS, Neale MC. Review of twin and family studies on neuroanatomic phenotypes and typical neurodevelopment Twin Res Hum Genet Off J Int Soc Twin Stud 2007;10:683–694.

  75. Neale MC, Cardon LR. Methodology for genetic studies of twins and families. Dordrecht: Kluwer Academic Press; 1992.

    Book  Google Scholar 

  76. Eaves LJ, Long J, Heath AC. A theory of developmental change in quantitative phenotypes applied to cognitive development. Behav Genet. 1986;16:143–62.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This manuscript was prepared under the salary support to JMB and MCN afforded by cooperative agreement 1U01DA041120.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James M. Bjork PhD.

Ethics declarations

Conflict of Interest

James M. Bjork declares that he has no conflict of interest.

Lisa K. Straub declares that she has no conflict of interest.

Rosellen G. Provost declares that she has no conflict of interest.

Michael C. Neale declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

Recruitment and procedures of each site and the coordinating center of the ABCD study are continually monitored by the ABCD External Advisory Board and the Bioethics and Medical Oversight advisory panel, and have been approved by either the local site Institutional Review Board (IRB) or by local IRB reliance agreements with the central IRB of the University of California-San Diego (site of the ABCD Coordinating Center).

Additional information

This article is part of the Topical Collection on Substance Use Disorders

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bjork, J.M., Straub, L.K., Provost, R.G. et al. The ABCD Study of Neurodevelopment: Identifying Neurocircuit Targets for Prevention and Treatment of Adolescent Substance Abuse. Curr Treat Options Psych 4, 196–209 (2017). https://doi.org/10.1007/s40501-017-0108-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40501-017-0108-y

Keywords

Navigation